期刊论文详细信息
Cancers | |
Systemic Therapy of Non-Resectable Metastatic Melanoma | |
Azadeh Orouji1  Sergij Goerdt1  | |
[1] Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany; | |
关键词: melanoma; metastatic; chemotherapy; targeted therapy; small molecules; | |
DOI : 10.3390/cancers2020955 | |
来源: mdpi | |
【 摘 要 】
In advanced metastatic melanoma (non-resectable stage III/IV), the prognosis still remains poor, with median survival times between six and twelve months. Systemic therapeutic approaches for metastatic melanoma include chemotherapy, immunotherapy, immunochemotherapy, small molecules and targeted therapy. In this review, we will focus on the various treatment modalities as well as new agents used for targeted therapy.
【 授权许可】
CC BY
© 2010 by the authors; licensee MDPI, Basel, Switzerland.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202003190053711ZK.pdf | 122KB | download |